Perilla frutescens: A Rich Source of Pharmacological Active Compounds

T Hou, VR Netala, H Zhang, Y Xing, H Li, Z Zhang - Molecules, 2022 - mdpi.com
Perilla frutescens (L.) Britton, an important pharmaceutical and nutraceutical crop, is widely
cultivated in East Asian countries. In this review, we present the latest research findings on …

Agents for the treatment of gout: current advances and future perspectives

X Zeng, Y Liu, Y Fan, D Wu, Y Meng… - Journal of Medicinal …, 2023 - ACS Publications
Gout is characterized by hyperuricemia and the deposition of monosodium urate (MSU)
crystals around joints. Despite the availability of several drugs on the market, its treatment …

Phytosynthesis of Silver Nanoparticles Using Perilla frutescens Leaf Extract: Characterization and Evaluation of Antibacterial, Antioxidant, and Anticancer Activities

NV Reddy, H Li, T Hou, MS Bethu, Z Ren… - International journal of …, 2021 - Taylor & Francis
Purpose The present study investigates the phytosynthesis of silver nanoparticles (AgNPs)
using Perilla frutescens leaf extract, which acts as a reducing agent for the conversion of …

Studies on the structure-activity relationship and interaction mechanism of flavonoids and xanthine oxidase through enzyme kinetics, spectroscopy methods and …

J Zhao, L Huang, C Sun, D Zhao, H Tang - Food chemistry, 2020 - Elsevier
In this study, some flavonoids were screened as potent xanthine oxidase (XO) inhibitors in
vitro. Flavonoid 9 was demonstrated to exhibit the inhibitory activity through a ping-pong …

Impact of ultrasound and conventional extraction techniques on bioactive compounds and biological activities of blue butterfly pea flower (Clitoria ternatea L.)

A Mehmood, M Ishaq, L Zhao, S Yaqoob… - Ultrasonics …, 2019 - Elsevier
The present study was conducted to evaluate the influence of ultrasound on bioactive
compounds and biological activities of blue butterfly pea flower (Clitoria ternatea L.). For this …

Novel reversible inhibitors of xanthine oxidase targeting the active site of the enzyme

R Rullo, C Cerchia, R Nasso, V Romanelli… - Antioxidants, 2023 - mdpi.com
Xanthine oxidase (XO) is a flavoprotein catalysing the oxidation of hypoxanthine to xanthine
and then to uric acid, while simultaneously producing reactive oxygen species. Altered …

Toward an understanding of structural insights of xanthine and aldehyde oxidases: an overview of their inhibitors and role in various diseases

R Kumar, G Joshi, H Kler, S Kalra… - Medicinal Research …, 2018 - Wiley Online Library
Almost all drug molecules become the substrates for oxidoreductase enzymes, get
metabolized into more hydrophilic products and eliminated from the body. These …

Hyperuricemia, the heart, and the kidneys–to treat or not to treat?

T Petreski, R Ekart, R Hojs, S Bevc - Renal failure, 2020 - Taylor & Francis
Background Hyperuricemia is a state in which the serum levels of uric acid are elevated. As
such it has a pronounced effect on vascular and renal function with their consequences …

Integrated in silico–in vitro strategy for the discovery of potential xanthine oxidase inhibitors from Egyptian propolis and their synergistic effect with allopurinol and …

DS Ghallab, E Shawky, AM Metwally, I Celik… - RSC …, 2022 - pubs.rsc.org
Xanthine oxidase (XO) has been well-recognized as a validated target for the treatment of
hyperuricemia and gout. Currently, there are two drugs in clinical use that shut down XO …

Trisubstituted barbiturates and thiobarbiturates: Synthesis and biological evaluation as xanthine oxidase inhibitors, antioxidants, antibacterial and anti-proliferative …

J Figueiredo, JL Serrano, E Cavalheiro… - European journal of …, 2018 - Elsevier
Barbituric and thiobarbituric acid derivatives have become progressively attractive to
medicinal chemists due to their wide range of biological activities. Herein, different series of …